Canton Strategic Holdings Inc (CNTN)

$1.87 0.00 (N/A)
Market Cap 144.22M
Revenue (ttm) 0.00
Net Income (ttm) -35.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 471,300
Avg Vol 1,062,358
Day's Range N/A - N/A
Shares Out 77.12M
Stochastic %K 41%
Beta 1.45
Analysts Strong Buy
Price Target N/A

Company Profile

Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States. It operates in two segments, Digital Asset Treasury and Clinical Stage Bio-technology. The company is involved in the operation of Canton Coin-centric digital asset treasury strategies, including validator operations and network participation; application support and strategic investments; collaboration and ecosystem advancement; capital raising and treasur...

Industry: Biotechnology
Sector: Healthcare
Phone: 732 889 3111
Address:
34 Shrewsbury Avenue, Suite 1C, Red Bank, United States
Revrasmilitia
Revrasmilitia Aug. 10 at 6:41 PM
$CC.X $CNTN https://www.youtube.com/watch?app=desktop&v=eUzhIBWTO68
0 · Reply
Revrasmilitia
Revrasmilitia Aug. 6 at 3:53 PM
$CC.X $CNTN Some AI on Canton vs. Circle’s Arc for what it’s worth… https://www.perplexity.ai/search/774eb0ac-0230-4f21-9dc6-04523d37ccbb
1 · Reply
Revrasmilitia
Revrasmilitia Aug. 6 at 2:09 PM
$CC.X $CNTN https://x.com/of_lovcen/status/2076256976934232371?s=46
0 · Reply
Revrasmilitia
Revrasmilitia Aug. 6 at 12:56 PM
$CC.X $CNTN https://x.com/zenithfdn/status/2084969013872898176?s=46
0 · Reply
Revrasmilitia
Revrasmilitia Aug. 5 at 3:23 PM
$CC.X $CNTN https://www.linkedin.com/pulse/canton-opportunity-why-cryptos-trojan-horse-financial-joris-delanoue-dz4te
0 · Reply
Revrasmilitia
Revrasmilitia Aug. 4 at 7:27 PM
$CC.X $CNTN DTCC official in an interview talking about the July 15th rollout and Canton. https://youtu.be/HVyPFv4PWlM
0 · Reply
Revrasmilitia
Revrasmilitia Aug. 3 at 10:55 PM
$CC.X $CNTN Franklin Templeton Digital Assets becoming a super validator.
0 · Reply
Revrasmilitia
Revrasmilitia Aug. 3 at 3:57 PM
$CNTN
0 · Reply
Revrasmilitia
Revrasmilitia Aug. 3 at 3:50 PM
$CC.X $CNTN https://blog.digitalasset.com/blog/myth-busters-canton-network
0 · Reply
Revrasmilitia
Revrasmilitia Aug. 3 at 12:36 AM
$CNTN Two great interviews. One with Yuval and one with Don Wilson from DRW. They are from 2025 but I think they must listen if you are investing in the Canton space. A bunch about the origin of Canton, their goals, and the large institutions backing Digital Asset and Canton. https://youtu.be/gJk6KkyziGc?is=dLwAe6DS21zVT-5K https://youtu.be/NuVdvPQtxeA?is=kLpcs5rUPGPCD8Mv
0 · Reply
Latest News on CNTN
Three New Directors Elected to the Board of Canton Strategic Holdings, Inc.

Jul 28, 2026, 8:15 AM EDT - 13 days ago

Three New Directors Elected to the Board of Canton Strategic Holdings, Inc.

Canton Strategic Holdings sells Gravitas Life Sciences

2026-07-23T12:11:09.000Z - 18 days ago

Canton Strategic Holdings sells Gravitas Life Sciences

Canton Strategic Holdings, Inc. Announces Sale of Gravitas Life Sciences, LLC

Jul 23, 2026, 8:00 AM EDT - 18 days ago

Canton Strategic Holdings, Inc. Announces Sale of Gravitas Life Sciences, LLC

Canton Strategic Holdings Transcript: Investor update

Jul 22, 2026, 11:00 AM EDT - 19 days ago

Canton Strategic Holdings Transcript: Investor update

Canton Strategic Holdings, Inc. Delivers Second Quarter Canton Network Ecosystem Update

Jul 17, 2026, 8:15 AM EDT - 24 days ago

Canton Strategic Holdings, Inc. Delivers Second Quarter Canton Network Ecosystem Update

Canton Strategic Holdings Transcript: AGM 2026

Jul 13, 2026, 2:00 PM EDT - 4 weeks ago

Canton Strategic Holdings Transcript: AGM 2026

Canton Strategic Holdings Proxy statement: Proxy filing

Jun 25, 2026, 8:00 AM EDT - 6 weeks ago

Canton Strategic Holdings Proxy statement: Proxy filing

Canton Strategic Holdings launches locking service for network infrastructure

2026-06-23T12:24:31.000Z - 6 weeks ago

Canton Strategic Holdings launches locking service for network infrastructure

Canton Strategic Holdings, Inc. Announces Launch of Locking Service to Support Network Infrastructure Providers

Jun 23, 2026, 8:15 AM EDT - 6 weeks ago

Canton Strategic Holdings, Inc. Announces Launch of Locking Service to Support Network Infrastructure Providers

Canton Strategic Holdings expects to be included in Russell 3000 and 2000

2026-06-18T12:23:30.000Z - 7 weeks ago

Canton Strategic Holdings expects to be included in Russell 3000 and 2000

Canton Strategic Holdings, Inc. Expected to Be Included in Russell 3000® and Russell 2000®

Jun 18, 2026, 8:15 AM EDT - 7 weeks ago

Canton Strategic Holdings, Inc. Expected to Be Included in Russell 3000® and Russell 2000®

CC

Canton Strategic Holdings announces $50M share repurchase program

2026-06-16T12:46:04.000Z - 7 weeks ago

Canton Strategic Holdings announces $50M share repurchase program

Canton Strategic Holdings, Inc. Announces Authorization of Share Repurchase Program

Jun 16, 2026, 8:34 AM EDT - 7 weeks ago

Canton Strategic Holdings, Inc. Announces Authorization of Share Repurchase Program

Canton Strategic Holdings Reports First Quarter 2026 Financial and Operational Results

May 13, 2026, 8:15 AM EDT - 3 months ago

Canton Strategic Holdings Reports First Quarter 2026 Financial and Operational Results

Canton Strategic Holdings Quarterly report: Q1 2026

May 13, 2026, 7:00 AM EDT - 3 months ago

Canton Strategic Holdings Quarterly report: Q1 2026

Canton Strategic Holdings Earnings release: Q1 2026

May 13, 2026, 7:00 AM EDT - 3 months ago

Canton Strategic Holdings Earnings release: Q1 2026

Canton Strategic Holdings Transcript: Investor Update

Apr 22, 2026, 10:00 AM EDT - 3 months ago

Canton Strategic Holdings Transcript: Investor Update

Canton Strategic Holdings, Inc. Presents Quarterly Canton Network Ecosystem Update

Apr 20, 2026, 9:15 AM EDT - 4 months ago

Canton Strategic Holdings, Inc. Presents Quarterly Canton Network Ecosystem Update

Canton Strategic Holdings Reports Full Year 2025 Financial and Operational Results

Mar 31, 2026, 8:10 AM EDT - 4 months ago

Canton Strategic Holdings Reports Full Year 2025 Financial and Operational Results

Canton Strategic Holdings Earnings release: Q4 2025

Mar 31, 2026, 7:00 AM EDT - 4 months ago

Canton Strategic Holdings Earnings release: Q4 2025

Canton Strategic Holdings Annual report: Q4 2025

Mar 31, 2026, 7:00 AM EDT - 4 months ago

Canton Strategic Holdings Annual report: Q4 2025

BitGo to Securely Store Digital Asset Treasury Holdings for Canton Strategic Holdings, Inc.

Mar 12, 2026, 8:00 AM EDT - 5 months ago

BitGo to Securely Store Digital Asset Treasury Holdings for Canton Strategic Holdings, Inc.

BTGO

Canton Strategic Holdings, Inc. Chairman and CEO Mark Wendland Elected to Canton Foundation Board

Mar 3, 2026, 8:15 AM EST - 5 months ago

Canton Strategic Holdings, Inc. Chairman and CEO Mark Wendland Elected to Canton Foundation Board

Tharimmune, Inc. Announces Corporate Rebrand to Canton Strategic Holdings, Inc., Marking Milestone in Canton Network Digital Asset Treasury Strategy

Feb 17, 2026, 7:10 AM EST - 6 months ago

Tharimmune, Inc. Announces Corporate Rebrand to Canton Strategic Holdings, Inc., Marking Milestone in Canton Network Digital Asset Treasury Strategy

Tharimmune, Inc. Appoints Mark Wendland Chairman of the Board and Names Angela Radkowski Chief Operating Officer

Feb 6, 2026, 8:15 AM EST - 6 months ago

Tharimmune, Inc. Appoints Mark Wendland Chairman of the Board and Names Angela Radkowski Chief Operating Officer

Tharimmune Elects Jill Sommers and William Wiley to Board of Directors

Feb 2, 2026, 8:15 AM EST - 6 months ago

Tharimmune Elects Jill Sommers and William Wiley to Board of Directors

Canton Strategic Holdings Transcript: EGM 2026

Jan 30, 2026, 10:00 AM EST - 6 months ago

Canton Strategic Holdings Transcript: EGM 2026

Canton Strategic Holdings Proxy statement: Proxy Filing

Jan 27, 2026, 7:00 AM EST - 6 months ago

Canton Strategic Holdings Proxy statement: Proxy Filing

Tharimmune Announces Expanded Role as Super Validator on Canton Network

Jan 26, 2026, 8:15 AM EST - 7 months ago

Tharimmune Announces Expanded Role as Super Validator on Canton Network

Tharimmune, Inc. Announces Closing of $55 Million Underwritten Registered Direct Offering

Jan 22, 2026, 4:12 PM EST - 7 months ago

Tharimmune, Inc. Announces Closing of $55 Million Underwritten Registered Direct Offering

Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering

Jan 20, 2026, 8:45 AM EST - 7 months ago

Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering

Canton Strategic Holdings Proxy statement: Proxy Filing

Jan 16, 2026, 7:00 AM EST - 7 months ago

Canton Strategic Holdings Proxy statement: Proxy Filing

Canton Strategic Holdings Registration statement: Registration Filing

Jan 9, 2026, 7:00 AM EST - 7 months ago

Canton Strategic Holdings Registration statement: Registration Filing

Canton Strategic Holdings Proxy statement: Proxy Filing

Jan 6, 2026, 7:00 AM EST - 7 months ago

Canton Strategic Holdings Proxy statement: Proxy Filing

Tharimmune, Inc. Statement on DTCC's Initiative to Tokenize U.S. Treasury Securities on the Canton Network

Dec 18, 2025, 8:15 AM EST - 8 months ago

Tharimmune, Inc. Statement on DTCC's Initiative to Tokenize U.S. Treasury Securities on the Canton Network

Canton Strategic Holdings Proxy statement: Proxy Filing

Dec 16, 2025, 7:00 AM EST - 8 months ago

Canton Strategic Holdings Proxy statement: Proxy Filing

Tharimmune, Inc. Appoints Jacob Asbury as Chief Financial Officer to Advance Canton Coin Treasury Strategy

Dec 12, 2025, 8:15 AM EST - 8 months ago

Tharimmune, Inc. Appoints Jacob Asbury as Chief Financial Officer to Advance Canton Coin Treasury Strategy

Canton Strategic Holdings Registration statement: Registration Filing

Dec 5, 2025, 7:00 AM EST - 8 months ago

Canton Strategic Holdings Registration statement: Registration Filing

Tharimmune Receives Positive FDA Feedback for TH104 Prophylaxis Program Against Respiratory Depression from Fentanyl and Ultrapotent Opioids

Nov 13, 2025, 8:05 AM EST - 9 months ago

Tharimmune Receives Positive FDA Feedback for TH104 Prophylaxis Program Against Respiratory Depression from Fentanyl and Ultrapotent Opioids

Canton Strategic Holdings Quarterly report: Q3 2025

Nov 12, 2025, 4:00 PM EST - 9 months ago

Canton Strategic Holdings Quarterly report: Q3 2025

Tharimmune, Inc. Closes $545 Million Private Placement to Establish Canton Coin Treasury Strategy

Nov 6, 2025, 4:16 PM EST - 9 months ago

Tharimmune, Inc. Closes $545 Million Private Placement to Establish Canton Coin Treasury Strategy

Tharimmune, Inc. Announces Private Placement of Approximately $540 Million Led by DRW and Liberty City Ventures to Establish Canton Coin Treasury Strategy

Nov 3, 2025, 9:04 AM EST - 10 months ago

Tharimmune, Inc. Announces Private Placement of Approximately $540 Million Led by DRW and Liberty City Ventures to Establish Canton Coin Treasury Strategy

Canton Strategic Holdings Registration statement: Registration Filing

Oct 17, 2025, 8:00 AM EDT - 10 months ago

Canton Strategic Holdings Registration statement: Registration Filing

Canton Strategic Holdings Proxy statement: Proxy Filing

Sep 18, 2025, 8:00 AM EDT - 11 months ago

Canton Strategic Holdings Proxy statement: Proxy Filing

Canton Strategic Holdings Proxy statement: Proxy Filing

Sep 8, 2025, 8:00 AM EDT - 1 year ago

Canton Strategic Holdings Proxy statement: Proxy Filing

Tharimmune Announces Upcoming Conference Presentations Highlighting Lead Asset TH104, A New Formulation Against Ultrapotent Opioids and Fentanyl

Sep 4, 2025, 8:01 AM EDT - 1 year ago

Tharimmune Announces Upcoming Conference Presentations Highlighting Lead Asset TH104, A New Formulation Against Ultrapotent Opioids and Fentanyl

Canton Strategic Holdings Registration statement: Registration Filing

Sep 3, 2025, 8:00 AM EDT - 1 year ago

Canton Strategic Holdings Registration statement: Registration Filing

Canton Strategic Holdings Registration statement: Registration Filing

Aug 26, 2025, 8:00 AM EDT - 1 year ago

Canton Strategic Holdings Registration statement: Registration Filing

Tharimmune Reports Pharmacokinetic Simulation Results for TH104 as Prophylaxis Against Respiratory Depression from Fentanyl and Ultrapotent Opioids, Highlighting Potential Superiority Over Existing Treatments

Aug 20, 2025, 8:00 AM EDT - 1 year ago

Tharimmune Reports Pharmacokinetic Simulation Results for TH104 as Prophylaxis Against Respiratory Depression from Fentanyl and Ultrapotent Opioids, Highlighting Potential Superiority Over Existing Treatments

Canton Strategic Holdings Quarterly report: Q2 2025

Aug 14, 2025, 2:00 PM EDT - 1 year ago

Canton Strategic Holdings Quarterly report: Q2 2025

Tharimmune Secures Key Global Patents for TH-104, Laying Foundation for Broader Indications Following Initial Development as a National Security Medical Countermeasure Against Weaponized Fentanyl

Aug 13, 2025, 8:01 AM EDT - 1 year ago

Tharimmune Secures Key Global Patents for TH-104, Laying Foundation for Broader Indications Following Initial Development as a National Security Medical Countermeasure Against Weaponized Fentanyl

Nancy Davis, Visionary Philanthropist and Founder of Race to Erase MS and Cure Addiction Now Appointed to the Tharimmune Board of Directors

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Nancy Davis, Visionary Philanthropist and Founder of Race to Erase MS and Cure Addiction Now Appointed to the Tharimmune Board of Directors

Tharimmune Issues Comprehensive Corporate Update including Lead TH104 as Critical National Security Solution Against Weaponized Fentanyl and TH023 Poised to Revolutionize Oral Antibody Delivery

Aug 4, 2025, 8:00 AM EDT - 1 year ago

Tharimmune Issues Comprehensive Corporate Update including Lead TH104 as Critical National Security Solution Against Weaponized Fentanyl and TH023 Poised to Revolutionize Oral Antibody Delivery

Tharimmune Announces Pricing of $1.74 Million Registered Direct Public Offering of Common Stock and Warrants

Jul 23, 2025, 10:15 PM EDT - 1 year ago

Tharimmune Announces Pricing of $1.74 Million Registered Direct Public Offering of Common Stock and Warrants

Canton Strategic Holdings Registration statement: Registration Filing

Jul 3, 2025, 8:00 AM EDT - 1 year ago

Canton Strategic Holdings Registration statement: Registration Filing

Canton Strategic Holdings Slides: Corporate Presentation

Jun 24, 2025, 2:00 AM EDT - 1 year ago

Canton Strategic Holdings Slides: Corporate Presentation

Tharimmune Announces Key Leadership Appointments Including James Gordon Liddy Joining Board of Directors

Jun 17, 2025, 8:01 AM EDT - 1 year ago

Tharimmune Announces Key Leadership Appointments Including James Gordon Liddy Joining Board of Directors

Canton Strategic Holdings Quarterly report: Q1 2025

May 11, 2025, 6:00 PM EDT - 1 year ago

Canton Strategic Holdings Quarterly report: Q1 2025

Tharimmune Presents Positive Clinical Data Highlighting TH104 Metabolic Profile and Advances Program for Prophylaxis Against Ultrapotent Opioid Exposure Following FDA Feedback

May 6, 2025, 8:01 AM EDT - 1 year ago

Tharimmune Presents Positive Clinical Data Highlighting TH104 Metabolic Profile and Advances Program for Prophylaxis Against Ultrapotent Opioid Exposure Following FDA Feedback

Canton Strategic Holdings Proxy statement: Proxy Filing

May 2, 2025, 8:00 AM EDT - 1 year ago

Canton Strategic Holdings Proxy statement: Proxy Filing

Tharimmune Abstracts Accepted for Presentation at Upcoming DDW and EASL Conferences

May 1, 2025, 8:01 AM EDT - 1 year ago

Tharimmune Abstracts Accepted for Presentation at Upcoming DDW and EASL Conferences

Tharimmune Appoints Clay Kahler and Gary Stetz to its Board of Directors

Apr 30, 2025, 8:01 AM EDT - 1 year ago

Tharimmune Appoints Clay Kahler and Gary Stetz to its Board of Directors

Canton Strategic Holdings Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Canton Strategic Holdings Proxy statement: Proxy Filing

Canton Strategic Holdings Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Canton Strategic Holdings Proxy statement: Proxy Filing

Tharimmune Advances TH104 for Prophylaxis Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback

Apr 28, 2025, 8:01 AM EDT - 1 year ago

Tharimmune Advances TH104 for Prophylaxis Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback

Tharimmune Strengthens Strategic Leadership with the Appointment of Vincent LoPriore to its Board of Directors

Apr 15, 2025, 9:00 AM EDT - 1 year ago

Tharimmune Strengthens Strategic Leadership with the Appointment of Vincent LoPriore to its Board of Directors

Tharimmune Announces Positive Data with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick(TM) Technology

Apr 7, 2025, 8:00 AM EDT - 1 year ago

Tharimmune Announces Positive Data with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick(TM) Technology

Tharimmune Announces Positive FDA Feedback on NDA Path for TH104 for Prophylaxis of Respiratory and/or CNS Depression for Ultrapotent Opioid Exposure

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Tharimmune Announces Positive FDA Feedback on NDA Path for TH104 for Prophylaxis of Respiratory and/or CNS Depression for Ultrapotent Opioid Exposure

Canton Strategic Holdings Annual report: Q4 2024

Mar 26, 2025, 8:00 AM EDT - 1 year ago

Canton Strategic Holdings Annual report: Q4 2024

Tharimmune Announces Positive Results for Novel Oral Monoclonal Antibody TH023 Targeting Tumor Necrosis Factor-alpha

Mar 24, 2025, 8:00 AM EDT - 1 year ago

Tharimmune Announces Positive Results for Novel Oral Monoclonal Antibody TH023 Targeting Tumor Necrosis Factor-alpha

Tharimmune Announces Positive Target Engagement with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick Technology

Mar 4, 2025, 7:00 AM EST - 1 year ago

Tharimmune Announces Positive Target Engagement with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick Technology

Tharimmune to Present at the Microcap Conference 2025

Jan 27, 2025, 8:30 AM EST - 1 year ago

Tharimmune to Present at the Microcap Conference 2025

Canton Strategic Holdings Slides: Corporate Presentation

Jan 9, 2025, 7:00 AM EST - 1 year ago

Canton Strategic Holdings Slides: Corporate Presentation

Canton Strategic Holdings Registration statement: Registration Filing

Dec 19, 2024, 7:00 AM EST - 1 year ago

Canton Strategic Holdings Registration statement: Registration Filing

Tharimmune Announces Phase 2 Study Plan for TH104 in Patients With Moderate-to-Severe Pruritus Associated With Primary Biliary Cholangitis and Provides a Business Update

Dec 16, 2024, 8:00 AM EST - 1 year ago

Tharimmune Announces Phase 2 Study Plan for TH104 in Patients With Moderate-to-Severe Pruritus Associated With Primary Biliary Cholangitis and Provides a Business Update

Tharimmune Announces $2.02 Million Private Placement to Advance Development Programs

Dec 6, 2024, 4:15 PM EST - 1 year ago

Tharimmune Announces $2.02 Million Private Placement to Advance Development Programs

Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease

Nov 18, 2024, 8:00 AM EST - 1 year ago

Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease

Tharimmune Granted European Patent for Delivery of Optimized Molecularly Targeted Therapeutics

Nov 13, 2024, 8:00 AM EST - 1 year ago

Tharimmune Granted European Patent for Delivery of Optimized Molecularly Targeted Therapeutics

Canton Strategic Holdings Quarterly report: Q3 2024

Nov 7, 2024, 7:00 AM EST - 1 year ago

Canton Strategic Holdings Quarterly report: Q3 2024

Tharimmune Announces Upcoming Conference Presentations

Nov 4, 2024, 9:00 AM EST - 1 year ago

Tharimmune Announces Upcoming Conference Presentations

Tharimmune Receives Positive Regulatory Feedback From EMA for TH104 Clinical Program for Chronic Pruritus in Primary Biliary Cholangitis

Oct 30, 2024, 8:00 AM EDT - 1 year ago

Tharimmune Receives Positive Regulatory Feedback From EMA for TH104 Clinical Program for Chronic Pruritus in Primary Biliary Cholangitis

Tharimmune Presents Favorable TH104 Phase 1 Clinical Data at the American College of Gastroenterology 2024 Annual Scientific Meeting

Oct 28, 2024, 9:00 AM EDT - 1 year ago

Tharimmune Presents Favorable TH104 Phase 1 Clinical Data at the American College of Gastroenterology 2024 Annual Scientific Meeting

Tharimmune Signs Nonbinding Letter of Intent to Merge With Intract Pharma to Create Transformative Oral Biologic Therapeutics Company

Sep 30, 2024, 7:00 AM EDT - 2 years ago

Tharimmune Signs Nonbinding Letter of Intent to Merge With Intract Pharma to Create Transformative Oral Biologic Therapeutics Company

Tharimmune Acquires Global License and Partners With Intract Pharma to Develop an Oral Formulation of Infliximab

Sep 16, 2024, 7:00 AM EDT - 2 years ago

Tharimmune Acquires Global License and Partners With Intract Pharma to Develop an Oral Formulation of Infliximab

Canton Strategic Holdings Quarterly report: Q2 2024

Aug 9, 2024, 7:00 AM EDT - 2 years ago

Canton Strategic Holdings Quarterly report: Q2 2024

Tharimmune Appoints Prof. David Jones of Newcastle University to its Scientific Advisory Board

Jul 22, 2024, 8:30 AM EDT - 2 years ago

Tharimmune Appoints Prof. David Jones of Newcastle University to its Scientific Advisory Board

Tharimmune Appoints Global Business Executive David H. Clarke as Key Strategic Advisor

Jul 17, 2024, 8:30 AM EDT - 2 years ago

Tharimmune Appoints Global Business Executive David H. Clarke as Key Strategic Advisor

Revrasmilitia
Revrasmilitia Aug. 10 at 6:41 PM
$CC.X $CNTN https://www.youtube.com/watch?app=desktop&v=eUzhIBWTO68
0 · Reply
Revrasmilitia
Revrasmilitia Aug. 6 at 3:53 PM
$CC.X $CNTN Some AI on Canton vs. Circle’s Arc for what it’s worth… https://www.perplexity.ai/search/774eb0ac-0230-4f21-9dc6-04523d37ccbb
1 · Reply
Revrasmilitia
Revrasmilitia Aug. 6 at 2:09 PM
$CC.X $CNTN https://x.com/of_lovcen/status/2076256976934232371?s=46
0 · Reply
Revrasmilitia
Revrasmilitia Aug. 6 at 12:56 PM
$CC.X $CNTN https://x.com/zenithfdn/status/2084969013872898176?s=46
0 · Reply
Revrasmilitia
Revrasmilitia Aug. 5 at 3:23 PM
$CC.X $CNTN https://www.linkedin.com/pulse/canton-opportunity-why-cryptos-trojan-horse-financial-joris-delanoue-dz4te
0 · Reply
Revrasmilitia
Revrasmilitia Aug. 4 at 7:27 PM
$CC.X $CNTN DTCC official in an interview talking about the July 15th rollout and Canton. https://youtu.be/HVyPFv4PWlM
0 · Reply
Revrasmilitia
Revrasmilitia Aug. 3 at 10:55 PM
$CC.X $CNTN Franklin Templeton Digital Assets becoming a super validator.
0 · Reply
Revrasmilitia
Revrasmilitia Aug. 3 at 3:57 PM
$CNTN
0 · Reply
Revrasmilitia
Revrasmilitia Aug. 3 at 3:50 PM
$CC.X $CNTN https://blog.digitalasset.com/blog/myth-busters-canton-network
0 · Reply
Revrasmilitia
Revrasmilitia Aug. 3 at 12:36 AM
$CNTN Two great interviews. One with Yuval and one with Don Wilson from DRW. They are from 2025 but I think they must listen if you are investing in the Canton space. A bunch about the origin of Canton, their goals, and the large institutions backing Digital Asset and Canton. https://youtu.be/gJk6KkyziGc?is=dLwAe6DS21zVT-5K https://youtu.be/NuVdvPQtxeA?is=kLpcs5rUPGPCD8Mv
0 · Reply
Revrasmilitia
Revrasmilitia Aug. 1 at 2:10 PM
$CC.X $CNTN
0 · Reply
Revrasmilitia
Revrasmilitia Jul. 31 at 7:24 PM
$CC.X $CNTN https://www.perplexity.ai/search/7f772bbd-b828-4f3f-827a-f6cf991d1021
0 · Reply
pennyheaven
pennyheaven Jul. 31 at 5:18 PM
$CNTN Thinking of starting a small position here and DCA as it drifts lower while waiting for the Clarity Act to pass. Once that happens this will soar, but if delayed or no passage this could sink to penny territory. Short term bearish, long term bullish.
1 · Reply
Revrasmilitia
Revrasmilitia Jul. 30 at 5:14 PM
$CNTN https://youtu.be/OrsNjjt4UFw?is=TpZrS08W2dhXNbHz
0 · Reply
Revrasmilitia
Revrasmilitia Jul. 30 at 11:43 AM
$CC.X $CNTN
0 · Reply
Revrasmilitia
Revrasmilitia Jul. 28 at 11:47 PM
$CC.X $CNTN https://youtu.be/JUIfSIA1NNo?is=SbHQsrRLm3rS4nUJ
0 · Reply
Revrasmilitia
Revrasmilitia Jul. 28 at 8:04 PM
$CNTN https://youtu.be/NuqFKwHtkg8?is=Zf9SfnDBzBkIZAh-
0 · Reply
Revrasmilitia
Revrasmilitia Jul. 28 at 1:09 PM
$CNTN Three new board members. https://cantonstrategic.com/news/three-new-directors-elected-to-the-board-of-canton-strategic-holdings-inc
0 · Reply
focafoca99
focafoca99 Jul. 28 at 12:39 PM
$CNTN elected three new directors to its board, strengthening governance as it advances the Canton Network strategy.
0 · Reply
Revrasmilitia
Revrasmilitia Jul. 26 at 2:19 PM
$CNTN https://youtu.be/IMOIn8E4isY?is=PIjAeHuYqL3PPULF
0 · Reply
Revrasmilitia
Revrasmilitia Jul. 23 at 2:25 PM
$CNTN
0 · Reply
Revrasmilitia
Revrasmilitia Jul. 23 at 2:22 PM
$CNTN
0 · Reply